Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626144 · ClinicalTrials.gov registry record
Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 170
- Enrollment target
NCT01626144 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 170 participants.
The verdict
NCT01626144 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
It is the investigators hypothesis that exemestane (EXE) metabolism is an important source of the inter-individual variation in EXE metabolic profiles and that polymorphisms in EXE-metabolizing enzymes may potentially play a role in affecting EXE therapeutic efficacy and toxicity. The goals of this clinical study are to (1) establish EXE metabolism profile kinetics, and (2) determine whether correlations exist in vivo between metabolizing enzyme genotype and urinary EXE metabolite profiles in women being treated with EXE. Together, these studies will allow us to fully characterize functionally-relevant polymorphisms in the EXE-metabolizing enzyme pathway that are potentially important in EXE clinical efficacy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626144
The ClinicalTrials.gov registry entry for NCT01626144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01626144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01626144 about?
NCT01626144 is a clinical study titled "Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles". It is the investigators hypothesis that exemestane (EXE) metabolism is an important source of the inter-individual variation in EXE metabolic profiles and that polymorphisms in EXE-metabolizing enzymes may potentially play a role in affecting EXE therapeutic efficacy and toxicity. The goals of this ...
What is the current status of trial NCT01626144?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2011-09. Estimated completion is 2018-05-01.
Who is sponsoring clinical trial NCT01626144?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.